Multi-level barriers to LTBI treatment: A research note

Journal of Immigrant and Minority Health

Volumn 12, Issue 4, 2010, Pages 544-550

  Hill, Linda ^a   Blumberg, Elaine ^b   Sipan, Carol ^b   Schmitz, Katharine ^b   West, Joshua ^b   Kelley, Norma ^b   Hovell, Melbourne ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Barriers to treatment; Compliance; Latent tuberculosis infection; Latino adolescents

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; FEMALE; HEALTH CARE DELIVERY; HISPANIC; HUMAN; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; QUESTIONNAIRE; UNITED STATES;

ADOLESCENT; ADULT; CALIFORNIA; FEMALE; HEALTH SERVICES ACCESSIBILITY; HISPANIC AMERICANS; HUMANS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 77955982301     PISSN: 15571912     EISSN: 15571920     Source Type: Journal    
DOI: 10.1007/s10903-008-9216-5     Document Type: Article

References (31)

1. World Health Organization. Tuberculosis fact sheet. March 2007. http://www.who.int/mediacentre/factsheets/fs104/en/. Accessed 22 July 2008.
2. World Health Organization. Strategic framework to decrease the burden of TB/HIV. Geneva, World Health Organization, 2002; WHO/CDS/TB/2002.296, WHO/HIV-AIDS/2002.2.
3. World Health Organization. Tuberculosis facts 2007. http://www.who.int/ tb/publications/2007/factsheet-2007.pdf. Accessed 22 July 2008.
4. E Vynnychy PE Fine 1997 The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection Epidemiol Infect 119 183 201 10.1017/S0950268897007917 (Pubitemid 27474799)
5. PA Selwyn D Hartel, et al. 1989 A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection N Engl J Med 320 545 50 1:STN:280:DyaL1M7islCnsg%3D%3D 2915665
6. Centers for Disease Control and Prevention. Reported tuberculosis in the US. Atlanta, GA: US DHHS, CDC; Sept 2006.
7. Centers for Disease Control and Prevention 1999 Tuberculosis elimination revisited: obstacles, opportunities, and a renewed commitment-advisory council for the elimination of tuberculosis (ACET) MMWR 48 RR09 1 13
8. Pediatric Tuberculosis Collaborative Group 2004 Targeted tuberculin skin testing and treatment of latent tuberculosis infection in children and adolescents Pediatrics 114 4 1175 201 10.1542/peds.2004-0809 (Pubitemid 41529798)
9. D Morisky V Ebin, et al. 2003 Assessment of tuberculosis treatment completion in an ethnically diverse population using two data sources Eval Health Prof 26 1 43 58 10.1177/0163278702250080 12629921 (Pubitemid 36206039)
10. WW Addington 1979 Patient compliance: the most serious remaining problem in the control of tuberculosis in the United States Chest 76 741 3 1:STN:280:DyaL3c%2FmvVejtQ%3D%3D 510021
11. W Fox 1983 Compliance of patients and physicians: experience and lessons from tuberculosis-I BMJ 287 33 5 10.1136/bmj.287.6384.33 1:STN:280: DyaL3s3jt1ahsA%3D%3D 6407684
12. E Sumartojo 1993 When tuberculosis treatment fails: a social behavioral account of patient adherence Am Rev Respir Dis 147 1311 20 1:STN:280: DyaK3s3kvFaisg%3D%3D 8484650
13. PD Mullen 1997 Compliance becomes concordance BMJ 314 691 2 1:STN:280:DyaK2s3is1WntA%3D%3D 9116538
14. Centers for Disease Control and Prevention. Approaches to improving adherence to antituberculosis therapy. MMWR 1993;42:74-5, 81.
15. JA Sbarbaro JB Sbarbaro 1994 Compliance and supervision of chemotherapy of tuberculosis Sem Respir Infect 9 120 7 1:STN:280:DyaK2M%2FmtlChsw%3D%3D
16. Volmink J, Garner P. Strategies for promoting completion of treatment in patients with tuberculosis. In: Garner P, Gelband H, Olliaro P, Salinas R, Volmink J, Wilkinson D, editors. Infectious diseases module of the Cochrane database of systematic reviews [updated 15 April 1997]. Oxford: Update Software; 1997 (available in the Cochrane Library).
17. M Starr S Sawyer, et al. 1999 A novel approach to monitoring adherence to preventive therapy for tuberculosis in adolescence J Pediatr Child Health 35 4 350 4 10.1046/j.1440-1754.1999.00371.x 1:STN:280:DyaK1MzovVagug%3D%3D (Pubitemid 29374420)
18. MA Barry L Shirley, et al. 1990 Tuberculosis infection in urban adolescents: results of a school based testing program AJPH 80 439 41 10.2105/AJPH.80.4.439 1:STN:280:DyaK3c7ps1Ciuw%3D%3D
19. MF Hovell CL Sipan EJ Blumberg CR Hofstetter D Slymen L Friedman K Moser NJ Kelley AY Vera 2003 Increasing Latino adolescents' adherence to treatment for latent Tuberculosis infection: a controlled trial AJPH 93 1871 7 10.2105/AJPH.93.11.1871
20. US Department of Health and Human Services. Office of disease prevention and health promotion: healthy people 2010, Vol. 1, 2nd ed. http://www. healthypeople.gov/Document/pdf/Volume1/14Immunization.pdf. Accessed 22 July 2008.
21. Centers for Disease Control, Prevention, Guide for Primary Care Providers. Targeted tuberculin testing, treatment of latent tuberculosis infection. Atlanta, GA: DHHS, CDC, National Center for HIV, STD, and TB Prevention, Division of Tuberculosis Elimination; 2005.
22. JF Kerner N Breen MC Tefft J Silsby G MarIn RJ Gamba 1996 A new measure of acculturation for hispanics: The bidimensional scale for hispanics (BAS) Hisp J Behav Sci 18 3 297 316 10.1177/07399863960183002
23. Centers for Disease Control and Prevention 1995 The use of preventive therapy for tuberculosis infection in the United States: recommendations of the Advisory Committee for Elimination of Tuberculosis MMWR 30 RR-8 9 12
24. PO Ozuah TP Ozuah RE Stein W Burton M Mulvihill 2001 Evaluation of a risk assessment questionnaire used to target tuberculin skin testing in children JAMA 285 4 451 3 10.1001/jama.285.4.451 1:STN:280:DC%2BD3M7nvVKhsg%3D%3D 11242430
25. FK Shieh G Snyder CR Horsburgh J Bernardo C Murphy JJ Saukkonen 2006 Predicting non-completion of treatment for latent tuberculosis infection: a prospective survey Am J Respir Crit Care Med 174 6 717 21 10.1164/rccm.200510- 1667OC 16809632 (Pubitemid 44395341)
26. M Jackson S Harrity H Hoffman A Catanzaro 2007 A survey of health professions students for knowledge, attitudes, and confidence about tuberculosis, 2005 BMC Publ Health 7 147 219 10.1186/1471-2458-7-219 (Pubitemid 47605270)
27. J Salazar-Schicchi V Jedlovsky A Ajayi PW Colson Y Hirsch-Moverman W El-Sadr 2004 Physician attitudes regarding bacille Calmette-Guerin vaccination and treatment of latent tuberculosis infection Int J Tuberc Lung Dis 8 12 1443 7 1:STN:280:DC%2BD2M%2FhtVynuw%3D%3D 15636490
28. Institute of Medicine. Ending neglect: the elimination of tuberculosis in the United States 2000. Geiter L, editor. Committee on the Elimination of Tuberculosis in the United States, Division of Health Promotion and Disease Prevention. Washigton, DC: National Academy Press.
29. Centers for Disease Control and Prevention. CDC's Response to ending neglect: The elimination of tuberculosis in the US 2002. http://www.cdc.gov/tb/ pubs/iom/iomresponse/default.htm, Accessed 22 July 2008.
30. Styblo K. Epidemiology of tuberculosis. Selected papers, vol 24. The Hague, The Netherlands: Royal Netherlands Tuberculosis Association (KNCV); 1991. p. 49-50.
31. Bennett D, Couval JM, Onorato MD, et al. Prevalence of TB infection in the US population 1999-2000. In: Program and abstracts of the American Public Health Association 131st annual meeting; San Francisco, California, November 15-19, 2003. Session 4199.